P2.09-41 Phase I/II Study Exploring Safety and Efficacy of Apl-101 Plus Frontline Osimertinib in EGFR-mutated Metastatic Non-small Cell Lung Cancer von Patel, B., Wu, N., Myles, S., Turlington, D., Yu, P., Saha, G., Rohatgi, A., Herzog, B.H., Ward, J.P., Baggstrom, M.Q., Waqar, S.N., Morgensztern, D., Govindan, R., Devarakonda, S.

Volltext

Induction of neuroendocrine differentiation in prostate cancer cells by Dovitinib (TKI-258) and associated therapeutic implications von Yadav, S, Li, J, Stockert, J.A.S, Herzog, B.H, O’Connor, J.O, Tewari, A.K.T, Yadav, K.K.Y

Volltext

102 - Induction of neuroendocrine differentiation in prostate cancer cells by Dovitinib (TKI-258) and associated therapeutic implications von Yadav, S., Li, J., Stockert, J.A.S., Herzog, B.H., O’Connor, J.O., Tewari, A.K.T., Yadav, K.K.Y.

Volltext

First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity von Bakker, A.B.H, Python, C, Kissling, C.J, Pandya, P, Marissen, W.E, Brink, M.F, Lagerwerf, F, Worst, S, van Corven, E, Kostense, S, Hartmann, K, Weverling, G.J, Uytdehaag, F, Herzog, C, Briggs, D.J, Rupprecht, C.E, Grimaldi, R, Goudsmit, J

Volltext

Validation of biomarkers of aging von Moqri, M., Herzog, C., Poganik, J.R., Ying, K.J., Justice, J.N., Belsky, D.W., Higgins-Chen, A.T., Chen, B.H., Cohen, A.A., Fuellen, G., Haegg, S., Marioni, R.E., Widschwendter, M., Fortney, K., Fedichev, P.O., Zhavoronkov, A., Barzilai, N., Lasky-Su, J., Kiel, D.P., Kennedy, B.K., Cummings, S., Slagboom, P.E., Verdin, E., Maier, A.B., Sebastiano, V., Snyder, M.P., Gladyshev, V.N., Horvath, S., Ferrucci, L.

Volltext bestellen

Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1 von RUDER, H, OTTO, G, SCHUTGENS, R. B. H, QUERFELD, U, WANDERS, R. J. A, HERZOG, K.-H, WOÊLFEL, P, POMER, S, SCHAÊRER, K, ROSE, G. A

Volltext

Lembophyllum bolivianum Herzog

Volltext bestellen